Skip to main content
PMC home page
Frontiers in Cell and Developmental Biology logoLink to Frontiers in Cell and Developmental Biology
. 2020 Mar 4;8:91. doi: 10.3389/fcell.2020.00091

The Impact of PM2.5 on the Host Defense of Respiratory System

Liyao Yang 1, Cheng Li 1, Xiaoxiao Tang 1,*
PMCID: PMC7064735  PMID: 32195248

Abstract

The harm of fine particulate matter (PM2.5) to public health is the focus of attention around the world. The Global Burden of Disease (GBD) Study 2015 (GBD 2015 Risk Factors Collaborators, 2016) ranked PM2.5 as the fifth leading risk factor for death, which caused 4.2 million deaths and 103.1 million disability-adjusted life-years (DALYs) loss, representing 7.6% of total global deaths and 4.2% of global DALYs. Epidemiological studies have confirmed that exposure to PM2.5 increases the incidence and mortality of respiratory infections. The host defense dysfunction caused by PM2.5 exposure may be the key to the susceptibility of respiratory system infection. Thus, this review aims to assess the impact of PM2.5 on the host defense of respiratory system. Firstly, we elaborated the epidemiological evidence that exposure to PM2.5 increases the risk of respiratory infections. Secondly, we summarized the experimental evidence that PM2.5 exposure increases the susceptibility of different pathogens (including bacteria and viruses) in respiratory system. Furthermore, here we discussed the underlying host defense mechanisms by which PM2.5 exposure increases the risk of respiratory infections as well as future perspectives.

Keywords: PM2.5, respiratory system, infection, susceptibility, host defense

Introduction

Exposure to air pollution, including gaseous pollution and particulate matter (PM) pollution, is a leading contributor to the Global Burden of Disease (GBD 2015 Risk Factors Collaborators, 2016). In recent years, more and more attention has been paid to the impact of PM pollution on public health. PM is a complex mixture of solids and liquids suspended in the air, which can be classified by its aerodynamic diameter as PM10 (<10 μm, inhalable particulate matter), PM2.5 (<2.5 μm, fine particulate matter) and PM0.1 (<0.1 μm, ultrafine particulate matter). PM originates from natural sources (such as dust, sea salt, and wildfires) and anthropogenic emissions (such as vehicles, household wood and coal burning as well as power plants and industry), and the latter accounts for most of the PM pollution (Cho et al., 2018). The components of PM are extremely complex, including inorganic components (such as heavy and transition metals, elemental carbon, and sulfuric/nitric/ammonia salts), organic components (such as polycyclic aromatic hydrocarbons) and biological components (such as fungi, spores, and viruses) (Zhang et al., 2015; Cho et al., 2018). There are certain differences in the source and composition of different types of particulate matter, and the harm to public health varies as well (Figure 1). Among them, PM2.5 was considered to be the most harmful one. PM2.5 has a large surface area and can adsorb a variety of toxic and harmful substances (Hsu et al., 2016). Because of its small particle size, it can penetrate deep into the lungs and deposit in the terminal bronchioles and alveoli with breath, and even enter the circulatory system through the gas-blood barrier (Pinkerton et al., 2000; Schulze et al., 2017). Exposure to PM2.5 can endanger multiple organs in the body, and even lead to systemic adverse effects (Chauhan and Johnston, 2003). Among them, the most common are the respiratory and cardiovascular systems (Xing et al., 2016). This review focuses on the respiratory system, the primary target organ for PM2.5 exposure.

FIGURE 1.

FIGURE 1

Open in a new tab

The size, main composition and deposition site in the lung of the particulate matter (PM). The average diameter of human hair is 60 μm, which approximately equivalents to six inhalable particulate matter (PM10, <10 μm in diameter, blue color), or twenty-four fine particulate matter (PM2.5, <2.5 μm in diameter, red color) or six hundred ultrafine particulate matter (PM0.1, <0.1 μm in diameter, green color). Particulate matter, with aerodynamic diameter 2.5–10 μm, is mainly deposited on the trachea. PM less than 2.5 μm in diameter poses the greatest problems, because it can get deep into the terminal bronchioles and alveoli, and some with <0.1 μm in diameter may even get into the bloodstream affecting other organs. 10X: The stuff in the dotted ring is magnified ten times.

PM2.5 may be the environmental risk factor that poses the greatest public health hazard. The GBD 2015 ranks PM2.5 as the fifth leading risk factor for death, with exposure to PM2.5 causing 4.2 million deaths (7.6% of global deaths) and loss of 10.31 million disability-adjusted life-years (DALYs) (4.2% of global DALYs) (Cohen et al., 2017). As claimed by the World Health Organization (WHO), 9 out of every 10 people in urban areas are exposed to high levels of PM2.5 (annual average concentration >10 μg/m3) from outdoor air pollution, and about 3 billion people using non-renewable fuels are exposed to serious indoor air pollution (World Health Organization [WHO], 2019). According to the Air Quality Life Index (AQLI), sustained exposure to an additional 10 μg/m3 of PM2.5 reduces life expectancy by 0.98 years1. In addition, an increase of 10 μg/m3 per day of PM2.5 concentration increases 0.29% of overall non-accidental mortality and 0.22% of respiratory disease mortalities (Chen et al., 2017).

A large number of epidemiological studies have shown that PM2.5 exposure is closely related to a variety of respiratory diseases (Jo et al., 2017; Wang C. et al., 2019). It is noteworthy that exposure to PM2.5 increases the susceptibility to respiratory infections. For instance, numerous clinical studies have found that PM2.5 exposure is positively correlated with the number of outpatient visits, emergency visits, and hospitalizations for acute upper or lower respiratory infections (Li et al., 2017; Xia et al., 2017; Strosnider et al., 2019). Related animal models also support the notion that PM2.5 exposure increases susceptibility to the lung infection (Yang et al., 2001; Sigaud et al., 2007; Zhao et al., 2014). However, the underlying mechanisms remain elusive. We speculate that PM2.5 exposure may impair the host defense of the respiratory system, making the body more susceptible to infection. The purpose of this article is to review the existing epidemiological and experimental evidence to support the above hypothesis and to summarize the possible underlying mechanisms.

The Epidemiological Evidence

The respiratory system is the primary route for inhaled PM2.5. Exposure to PM2.5 can cause the development and progression of acute and chronic lung diseases, such as tracheal and pulmonary inflammation (Kampa and Castanas, 2008; Jedrychowski et al., 2013; Ge et al., 2018), asthma and its acute exacerbations (Habre et al., 2014; Zheng et al., 2015), chronic obstructive pulmonary disease (COPD) and its acute exacerbations (Faustini et al., 2013; Tsai et al., 2013). We are concerned with the fact that PM2.5 exposure increases the susceptibility to respiratory infections.

Outpatient, emergency, and hospitalization-related data on respiratory infections confirmed that PM2.5 exposure was positively associated with the increased respiratory infections. Li et al. (2017) studied the effects of air pollution on outpatients’ acute respiratory outcomes and their study indicated that PM2.5 exposure was positively correlated with outpatient visits for upper respiratory tract infection (URTI). A study in the U.S. state of Georgia also showed that pediatric emergency visits for URTI were associated with PM2.5 concentrations (Strickland et al., 2016). Another study reported that PM2.5 was significantly associated with emergency room visits for respiratory diseases, particularly for URTI and lower respiratory tract infection (LRTI) (Xu et al., 2016). Recently, Strosnider et al. (2019) confirmed that PM2.5 exposure was positively correlated with emergency visits for multiple respiratory diseases, including respiratory infections. In addition, Xia et al. (2017) studied the association between different types of air pollution and respiratory hospitalization and found that short-term exposure of PM2.5 was positively correlated with the number of hospitalizations for acute respiratory infections. Similarly, another four studies also supported a significant positive correlation between PM2.5 and the number of hospitalizations for URTI and LRTI (Belleudi et al., 2010; Li et al., 2018; Liu et al., 2019b; Zhang D. et al., 2019).

The effect of PM2.5 exposure on respiratory infections is not immediate, but there is a certain lag effect. For example, PM2.5 exposure was positively associated with an increase in hospitalization for acute respiratory infections, but this correlation was delayed by 7–13 days (Xia et al., 2017). Liang et al. (2014) analyzed the time curve of PM2.5 concentration and human influenza in Beijing urban area from 2008 to 2011, and proved that there was a significant correlation between PM2.5 exposure and influenza, but this correlation showed a 1–2 months delay. In a study of 150,000 cases, Horne et al. (2018) investigated the relationship between PM2.5 and the health status of patients with acute LRTI and discovered that the association of PM2.5 exposure with respiratory syncytial virus (RSV) infection occurred in 2–4 weeks. The hysteresis effects varied in different studies. Therefore, when investigating the association between PM2.5 exposure and respiratory infections, researchers may need to choose the appropriate follow-up time.

Exposure to PM2.5 increases the susceptibility to respiratory infections, especially in children and the elderly, as well as the vulnerable groups with hereditary or underlying diseases. A study on the relationship between PM2.5 and the health status of patients with acute LRTI revealed that about 77% of the subjects were infants aged 0–2 years. RSV and influenza virus were the main pathogens (Horne et al., 2018). Another study on risks of respiratory infections associated with air pollution in China showed that children under the age of 14 were the predominantly susceptible population of acute respiratory infections caused by air pollution, accounting for 80% of hospitalized cases of respiratory system infections in the study (Xia et al., 2017). Similarly, Liu et al. (2019b) found that students aged 6–17 years were more vulnerable to PM2.5 exposure. The maternal exposure to air pollution before birth may result in an impaired lung development and increase the risk of respiratory system infections (Pinkerton and Joad, 2006; Jedrychowski et al., 2013). In addition, by analyzing the association between PM2.5 pollution and hospital emergency room visits for total and cause-specific respiratory diseases in urban areas in Beijing, Xu et al. (2016) found that people over 60 years of age demonstrated a higher risk of respiratory disease (including URTI and LRTI) after PM2.5 exposure. Exposure to PM2.5 is more likely to cause respiratory infections in people with congenital immune deficiencies due to hereditary diseases. For instance, exposure to PM2.5 in patients with cystic fibrosis has been reported to be associated with the acquisition of Pseudomonas aeruginosa (P. aeruginosa). During the follow-up period, each additional PM2.5 exposure of 10 μg/m3 increased the risk of 24% P. aeruginosa acquisition (Psoter et al., 2015). Another study has found that each additional PM2.5 exposure of 10 μg/m3 increased the risk of methicillin-resistant Staphylococcus aureus (MRSA) by 68% (Psoter et al., 2017).

The Experimental Evidence

In vivo studies have shown that as a risk factor for respiratory infection, PM2.5 exposure, can prime the lung for greater susceptibility to pathogens by impairing the respiratory host defense. Yang et al. (2001) found that PM exposure suppressed macrophage function and slowed the pulmonary clearance of Listeria monocytogenes (L. monocytogenes) in rats. Another research discovered that the colony-forming units (CFUs) of P. aeruginosa detected in the lung were significantly greater in the PM-exposed mice compared to the control mice (Liu et al., 2019a). Zhao et al. (2014) found that prior PM2.5 exposure markedly increased the susceptibility of rats to subsequent Staphylococcus aureus (S. aureus) infection. Similarly, Duan et al. (2013) found that PM2.5 exposure increased the susceptibility of rats to Klebsiella pneumoniae (K. pneumoniae) infection. Sigaud et al. (2007) and Migliaccio et al. (2013) established an exposure model in mice and subsequently infected with Streptococcus pneumoniae (S. pneumoniae). They found that PM exposure reduced bacterial clearance in the lungs of mice. In addition, Ma et al. (2017) discovered that exposure to PM2.5 lowers influenza virus resistance. We summarized the in vivo experimental studies of PM2.5 on respiratory host defense (Table 1).

TABLE 1.

Summary of in vivo experimental studies of PM2.5 on respiratory host defense.

Animal species Pathogen Exposure method Effects on respiratory host defense References
SD rats Listeria Intranasal instillation Exposure to diesel exhaust particles (DEP) decreased the ability of macrophages to produce antimicrobial oxidants in response to Listeria, which may play a role in the increased susceptibility of rats to pulmonary infection Yang et al., 2001
BALB/c mice S. pneumoniae Intranasal instillation The combination of γ-interferon (IFN-γ) priming and concentrated ambient particles (CAPs) exposure led to an inflamed alveolar milieu where oxidant stress caused loss of antibacterial functions in alveolar macrophages (AMs) and recruited polymorphonuclear granulocytes (PMNs) Sigaud et al., 2007
BALB/c mice S. pneumoniae Whole-body exposure (smoking) Exposure to wood smoke-derived particulate matter decreased the ability of pulmonary macrophages to effectively mount a defense against infection, and appeared to be mediated via RelB activation Migliaccio et al., 2013
SD rats K. pneumoniae Intranasal instillation PM2.5 exposure increased the susceptibility of the rats to K. pneumoniae infection and decreased bacterial clearance. Its mechanism may be related to the impairment of bronchial mucociliary system and interaction of cytokines. Duan et al., 2013
Wistar rats S. aureus Intranasal instillation Exposure to PM2.5 increased susceptibility to respiratory S. aureus infection in rats via reducing pulmonary natural killer cells and suppressing the phagocytosis ability of AMs. Zhao et al., 2014
Mice* Influenza virus Intranasal inhalation Long-term exposure to PM2.5 lowered influenza virus resistance via down-regulating pulmonary macrophage Kdm6a and mediated histones modification in IL-6 and IFN-β promoter regions Ma et al., 2017
C57BL/6J mice P. aeruginosa Intracheal instillation PM disrupted tight junctions (TJs) via oxidative stress to promote bacterial infection Liu et al., 2019a
Open in a new tab

*The specific strain is not indicated in the literature.

In vitro experiments have also confirmed that PM2.5 exposure increased the susceptibility of respiratory infection. For example, PM2.5-pretreated A549 cells have a significantly increased risk of infection with Mycobacterium tuberculosis (M. tuberculosis) (Rivas-Santiago et al., 2015), and PM can disrupt the airway epithelium through oxidative burst to promote P. aeruginosa infection (Liu et al., 2019a). Similarly, Chen et al. (2018) found that PM suppressed airway antibacterial defense, causing an increased susceptibility to P. aeruginosa. In addition, adhesion is the key to microbial invasion of the respiratory tract. PM increased the binding of S. pneumoniae to both primary alveolar macrophages (AMs) and the murine macrophage cell line J774 A.1 but decreased internalization of bacteria (Zhou and Kobzik, 2007). Mushtaq et al. (2011) have discovered that urban PM increased the adhesion of S. pneumoniae to human tracheal epithelial cells. We also summarized the in vitro experimental studies of PM2.5 on respiratory host defense (Table 2).

TABLE 2.

Summary of in vitro experimental studies of PM2.5 on respiratory host defense.

Cell line Pathogen Culture method Effects on respiratory host defense References
Murine primary alveolar macrophages and the murine macrophage cell line (J774 A.1) S. pneumoniae Submerged Soluble metal, especially iron, in the PM played an important role in the inhibition of macrophage phagocytosis killing of S. pneumoniae Zhou and Kobzik, 2007
A549 cells and Human primary bronchial epithelial cells (HBEpC) S. pneumoniae Submerged Urban PM increased adhesion of S. pneumoniae to human airway epithelial cells. PM-stimulated adhesion was mediated by oxidative stress and platelet-activating factor receptor (PAFR) Mushtaq et al., 2011
A549 cells M. tuberculosis Submerged Exposure of A549 cells to PM induced cellular senescence, a likely cause of the observed downregulation of HBD-2 and HBD-3 and the subsequent loss of M. tuberculosis growth control Rivas-Santiago et al., 2015
BEAS-2B P. aeruginosa Submerged PM impaired airway epithelial defense by impeding the induction of HBD-2 via an oxidative burst, potentially causing an increased susceptibility to infection Chen et al., 2018
BEAS-2B P. aeruginosa Submerged PM disrupted tight junctions (TJs) via oxidative stress to promote bacterial infection Liu et al., 2019a
Open in a new tab

Possible Mechanisms

PM2.5 exposure impairs the host defense of respiratory system causing the body more susceptible to infection. We dissect the underlying mechanisms from the following three aspects: defective airway epithelial host defense functions, alterations in respiratory microecology, insufficiency and dysfunction of immune cells (Figure 2).

FIGURE 2.

FIGURE 2

Open in a new tab

Possible mechanisms underlying defective host defense of respiratory system by PM2.5 exposure. (A) Defective airway epithelial host defense functions. PM2.5 exposure increases adhesion of pathogens to epithelial cells, impairs epithelial barrier function, compromises mucociliary clearance, and reduces antimicrobial activity. (B) Alterations in respiratory microecology. PM2.5 exposure decreases indigenous microflora and increases the content of conditional pathogenic microorganisms. (C) Insufficiency and dysfunction of immune cells. PM2.5 exposure decreases the number of natural killer cells and impairs the phagocytic capacity of alveolar macrophages.

Defective Airway Epithelial Host Defense Functions

At the interface between the external environment and the host, the airway epithelium serves as the first line of host defense against pathogens. The airway epithelial host defense functions mainly include mucociliary clearance, the barrier functions of the epithelium, and the secretion of a number of proteins and peptides with antimicrobial activities (Figure 3A). Mucociliary clearance in the airway epithelium is a critical protective function and is essential for the clearance of respiratory pathogens. In general, most foreign bodies inhaled into the lungs can be removed in time by the mucociliary clearance system. However, it has been reported that PM2.5 exposure decreased bacterial clearance by impairing the bronchial mucociliary system (Duan et al., 2013). Mucin hyperproduction or hypersecretion is a common reason for decreased mucociliary clearance. Val et al. (2012) found that the expression of MUC5AC, one of the predominant mucins produced by the airway epithelium, was upregulated via the epidermal growth factor receptor (EGFR) pathway after PM2.5 exposure in mice (Figure 3B).

FIGURE 3.

FIGURE 3

Open in a new tab

Molecular mechanisms underlying PM2.5-induced defective airway epithelial host defense functions. (A) Major host defense functions of normal and PM2.5-exposured airway epithelia. Normal airway epithelia are protected from pathogens mainly by mucociliary clearance, the barrier functions of the epithelium, and the secretion of a number of AMPs with antimicrobial activities. However, PM2.5 exposure disrupts these host defense functions, resulting in more pathogens in the airways. (B) Underlying molecular mechanisms: ① PM2.5 → EGFR ↑→ MUC5AC ↑→ Mucus ↑→ Mucociliary clearance ↓: PM2.5 up-regulates the expression of MUC5AC (one of the predominant mucins produced by the airway epithelium) by activating EGFR pathway, resulting in decreased mucociliary clearance. ② PM2.5 → IL-6 ↑→ AKT ↑→ NF-κB ↑→ ICAM-1 ↑→ Pathogen adhesion ↑: PM2.5 activates AKT/NF-κB pathway through IL-6 paracrine signaling, which then up-regulates the expression of ICAM-1 (an important glycoprotein on the cell surface) in the lung to increase the adhesion of pathogens to the airway epithelium. ③ PM2.5 → ROS ↑→ ERK-1/2 ↑→ Claudin-1 ↓→ TJs ↓→ Epithelial barrier ↓: PM2.5 down-regulates the expression of claudin-1 (a major structural protein of TJs) via generating ROS and activating ERK1/2 pathway, resulting in more pathogens to translocate across the disrupted epithelial barrier. ④ PM2.5 →β-defensin ↓→ AMPs ↓→ Antimicrobial activity ↓: PM2.5 inhibits the expression and secretion of β-defensin (one of the major AMPs in ASL), which allows more pathogens to survive and exacerbates respiratory infections.

The adhesion of pathogens to host cells is a prerequisite for infection. A study has reported that exposure to urban PM increased the adhesion of S. pneumoniae to human airway epithelial cells, and the addition of N-acetylcysteine (NAC, an antioxidant) reversed this process, possibly be related to reactive oxygen species (ROS) produced by oxidative stress (Mushtaq et al., 2011). In addition, Liu et al. (2018) reported that ROS induced by PM2.5 activated the AKT/STAT3/NF-κB pathway through IL-6 paracrine signaling, which then upregulated the expression of intercellular adhesion molecule-1 (ICAM-1, an important glycoprotein on the cell surface) in the lung to increase the adhesion of pathogens to the airway epithelium (Figure 3B). Woo et al. (2018) also found that PM2.5 could enhance the adhesion of P. aeruginosa to epithelial cells, the mechanism of which depended on the increased bacterial surface hydrophobicity and damaged human cell plasma membrane by PM2.5.

Tight junctions (TJs) are the significant protein complexes at cell-cell interfaces that connect adjacent cells with each other to form lung epithelial barrier against pathogens (Schlingmann et al., 2015). Lack of an intact TJs structure, the airway epithelial barrier cannot keep tight. It will allow pathogens to translocate across the barrier, making the lungs more susceptible to infection. A recent study reported that PM impaired TJs of airway epithelial barrier via oxidative stress to promote P. aeruginosa infection (Liu et al., 2019a). Claudin-1 is a major structural protein of TJs. Similarly, another study also discovered that exposure to PM downregulated claudin-1 expression in human airway cells via the ERK1/2 signaling pathway (Kim et al., 2017) (Figure 3B).

The airway epithelial cells are covered with a very thin fluid layer (airway surface liquid, ASL), which is an important component of the respiratory innate immunity. Antimicrobial peptides (AMPs) content is a significant and indispensable factor affecting the antibacterial effect of ASL. AMPs include salivary agglutinin (SAG), beta-defensins, lactoferrin, secretory IgA, and surfactant protein D (SPD) (Fabian et al., 2012; Kendall et al., 2013; Vargas Buonfiglio et al., 2018). Zhang S. et al. (2019) found that PM2.5 exposure attenuated the antibacterial activity of airways by down-regulating the expression of SAG. In addition, several studies indicated that PM2.5 exposure down-regulated airway β-defensin expression levels through oxidative stress (Rivas-Santiago et al., 2015; Vargas Buonfiglio et al., 2017; Chen et al., 2018). Collectively, these studies suggested that PM2.5 could compromise the host defense function of airway epithelial cells by downregulating the expression of AMPs (Figure 3B).

Alterations in Respiratory Microecology

In healthy humans, the low respiratory tract is usually sterile, and without permanent bacterial colonization, while the upper respiratory tract (especially oropharynx) has a normal bacterial flora, which is also an important component of respiratory tract’s natural immune defense, providing a biological barrier against foreign matter or pathogenic microorganisms througha space-occupying effect, nutritional competition, and secretion of bacteriostatic or bactericidal substances (Akata et al., 2016; Marsh et al., 2016; Wang L. et al., 2019). The oropharyngeal microecosystems of rats changed following PM exposure, including a decline of indigenous microflora and an increase of the content of conditional pathogenic microorganisms (Xiao et al., 2013). By analyzing 16S rRNA sequencing of respiratory tract lavage fluid, a recent study confirmed that there is a link between PM2.5 exposure and alterations of the respiratory tract microecology (Yang et al., 2019).

Insufficiency and Dysfunction of Immune Cells

A variety of immune cells are resident in the respiratory tract, including AMs, polymorphonuclear granulocytes (PMNs), lymphocytes, etc. Their numbers and functions are essential to protect against pathogen invasion. Zhao et al. (2014) found that the reduction of phagocytic phagocytosis caused by PM2.5 exposure was related to a decrease of NKs in a PM2.5 exposure rat model and subsequently infected with S. aureus. Another research found that PM2.5 exposure can trigger a Th2-type immune response and reduce the phagocytic capacity of AMs, which may be related to Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4) (Zhao et al., 2012). In addition, Ma et al. (2017) found that long-term exposure to PM2.5 lowered influenza virus resistance via down-regulating pulmonary macrophage Kdm6a and mediated histones modification in IL-6 and IFN-β promoter regions. Another two studies indicated that PM2.5 can be used as an immunity inhibitor to reduce the phagocytic capacity of macrophages, thereby increasing the susceptibility to S. pneumoniae infection (Migliaccio et al., 2013; Zhao et al., 2014). PM exposure has also been indicated to decrease the ability of macrophages to produce antimicrobial oxidants in response to L. monocytogenes, which may play a role in the increased susceptibility of rats to respiratory infection (Yang et al., 2001).

Conclusion and Future Perspectives

In summary, there are sufficient epidemiological evidences from outpatient, emergency and hospitalization-related data that exposure to PM2.5 increases susceptibility to respiratory infections. However, studies on the association between PM2.5 exposure and age, gender, and specific pathogens remain controversial. In the future, a meta-analysis of existing research can be attempted to further confirm the susceptible population of PM2.5 exposure to respiratory infections. We notice that there is a lag effect in the association between PM2.5 exposure and respiratory infections. This may be due to the variations of the average incubation period of different pathogens. We also note that only a few epidemiological studies have reported the relationship between PM2.5 exposure and the infection rates of specific pathogens associated with respiratory infections. Is there a specific pathogen preference for respiratory infections caused by PM2.5 exposure? This still requires the unremitting efforts of the researchers.

In vivo and in vitro studies have shown that PM2.5 exposure is beneficial to the adhesion, colonization and growth of microorganisms, but it is not conducive to the removal from the body. However, most of the current in vivo experiments establish a PM2.5 exposure animal model by intratracheal instillation. This model usually affects the lower respiratory tract and is prone to uneven distribution in the lung lobes. Concentration and enrichment of PM2.5 aerosol combined with the oral-inhalation or whole-body exposure system may be the best model for simulating human exposure. In recent years, an emerging technology has appeared, combing versatile aerosol concentration enrichment system (VACES) with oral-inhalation or whole-body exposure system. The advantages and disadvantages of these two models are shown in Table 3. Furthermore, current in vitro experiments are limited to epithelial cells- and alveolar macrophage-mediated innate immune responses, lacking attention to adaptive immune responses. Either in vivo or in vitro, the exposure doses currently used in the study are usually based on the corresponding toxicity experiments. How can such exposure levels represent real-world or clinical scenarios?

TABLE 3.

Strengths and weaknesses of intratracheal instillation and versatile aerosol concentration enrichment system (VACES) on PM2.5 exposure to experimental rodents.

Method Intratracheal instillation Versatile aerosol concentration enrichment system (VACES)
Oral-inhalation exposure system Whole-body exposure system
Equipment cost Low High High
Operation difficulty High Low Low
Animal activity level Limited Limited Unlimited
Dosage Instilled dosage (mg/kg of body weight or mg/animal) Defined by the PM2.5 concentration (mg/m3)
Deposition Uneven distribution in the lung lobes Even distribution in the lung lobes
Application Acute model, only affecting the lower respiratory tract Acute or chronic model, affecting the whole respiratory tract
Source of PM2.5 PM2.5 powder is usually obtained through high volume air sampler collection, ultrasonic elution and vacuum freeze drying. Different elution methods have an impact on the composition of PM2.5 obtained PM2.5 is collected directly from the air and concentrated for the required exposure concentration. The composition of PM2.5 will be affected by the spatial and temporal distribution of the collection sites
Open in a new tab

PM2.5 exposure may impair the host defense system of respiratory system, making the organism susceptible to infection. In brief, the possible mechanisms include defective airway epithelial host defense functions, alterations of the respiratory tract microecology, and insufficient number or dysfunction of immune cells (Figure 2). However, there is still a lack of robust research on molecular mechanisms. Further efforts are desperately needed to elucidate the underlying mechanisms at the molecular level.

Author Contributions

XT conceived and designed the manuscript. LY, CL, and XT wrote the manuscript and critically revised it. CL and XT generated the figures. XT provided guidance and edited the manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This is a short text to acknowledge the contributions of specific colleagues, institutions, or agencies that aided the efforts of the authors.

Abbreviations

AMPs

antimicrobial peptides

AMs

alveolar macrophages

AQLI

Air Quality Life Index

ASL

airway surface liquid

CFUs

colony-forming units

COPD

chronic obstructive pulmonary disease

DALYs

disability-adjusted life-years

GBD

global burden of disease

ICAM-1

intercellular adhesion molecule-1

K. pneumoniae

klebsiella pneumoniae

L. monocytogenes

Listeria monocytogenes

LRTI

lower respiratory tract infection

M. tuberculosis

Mycobacterium tuberculosis

MRSA

Methicillin-resistant Staphylococcus aureus

NAC

N-acetylcysteine

NKs

natural killer cells

P. aeruginosa

Pseudomonas aeruginosa

PM

particulate matter

PM10

inhalable particulate matter

PM2.5

fine particulate matter

PM0.1

ultrafine particulate matter

PMNs

polymorphonuclear granulocytes

ROS

reactive oxygen species

RSV

respiratory syncytial virus

S. aureus

Staphylococcus aureus

S. pneumoniae

Streptococcus pneumoniae

SAG

salivary agglutinin

SPD

surfactant protein D

TJs

tight junctions

TLR2

Toll-like receptor 2

TLR4

Toll-like receptor 4

URTI

upper respiratory tract infection

VACES

versatile aerosol concentration enrichment system

WHO

World Health Organization.

Funding. The authors were supported by the National Thousand Young Talents Program (XT), the National Natural Science Foundation of China (81770015, XT), Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (2017BT01S155), and Open Project of State Key Laboratory of Respiratory Disease (SKLRD-OP-201906).

References

  1. Akata K., Yatera K., Yamasaki K., Kawanami T., Naito K., Noguchi S., et al. (2016). The significance of oral streptococci in patients with pneumonia with risk factors for aspiration: the bacterial floral analysis of 16S ribosomal RNA gene using bronchoalveolar lavage fluid. BMC Pulm. Med. 16:79. 10.1186/s12890-016-0235-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Belleudi V., Faustini A., Stafoggia M., Cattani G., Marconi A., Perucci C. A., et al. (2010). Impact of fine and ultrafine particles on emergency hospital admissions for cardiac and respiratory diseases. Epidemiology 21 414–423. 10.1097/EDE.0b013e3181d5c021 [DOI] [PubMed] [Google Scholar]
  3. Chauhan A. J., Johnston S. L. (2003). Air pollution and infection in respiratory illness. Br. Med. Bull. 68 95–112. 10.1093/bmb/ldg022 [DOI] [PubMed] [Google Scholar]
  4. Chen R., Yin P., Meng X., Liu C., Wang L., Xu X., et al. (2017). Fine particulate air pollution and daily mortality. A nationwide analysis in 272 Chinese cities. Am. J. Respir. Crit. Care Med. 196 73–81. 10.1164/rccm.201609-1862OC [DOI] [PubMed] [Google Scholar]
  5. Chen X., Liu J., Zhou J., Wang J., Chen C., Song Y., et al. (2018). Urban particulate matter (PM) suppresses airway antibacterial defence. Respir. Res. 19:5. 10.1186/s12931-017-0700-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cho C. C., Hsieh W. Y., Tsai C. H., Chen C. Y., Chang H. F., Lin C. S. (2018). In vitro and in vivo experimental studies of PM2.5 on disease progression. Int. J. Environ. Res. Public Health 15:1380. 10.3390/ijerph15071380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cohen A. J., Brauer M., Burnett R., Anderson H. R., Frostad J., Estep K., et al. (2017). Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the global burden of diseases study 2015. Lancet 389 1907–1918. 10.1016/S0140-6736(17)30505-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Duan Z., Du F. Y., Yuan Y. D., Zhang Y. P., Yang H. S., Pan W. S. (2013). [Effects of PM2.5 exposure on Klebsiella pneumoniae clearance in the lungs of rats]. Zhonghua Jie He He Hu Xi Za Zhi 36 836–840. [PubMed] [Google Scholar]
  9. Fabian T. K., Hermann P., Beck A., Fejerdy P., Fabian G. (2012). Salivary defense proteins: their network and role in innate and acquired oral immunity. Int. J. Mol. Sci. 13 4295–4320. 10.3390/ijms13044295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Faustini A., Stafoggia M., Colais P., Berti G., Bisanti L., Cadum E., et al. (2013). Air pollution and multiple acute respiratory outcomes. Eur. Respir. J. 42 304–313. 10.1183/09031936.00128712 [DOI] [PubMed] [Google Scholar]
  11. GBD 2015 Risk Factors Collaborators (2016). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 1659–1724. 10.1016/S0140-6736(16)31679-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ge E., Lai K., Xiao X., Luo M., Fang Z., Zeng Y., et al. (2018). Differential effects of size-specific particulate matter on emergency department visits for respiratory and cardiovascular diseases in Guangzhou, China. Environ. Pollut. 243(Pt A) 336–345. 10.1016/j.envpol.2018.08.068 [DOI] [PubMed] [Google Scholar]
  13. Habre R., Moshier E., Castro W., Nath A., Grunin A., Rohr A., et al. (2014). The effects of PM2.5 and its components from indoor and outdoor sources on cough and wheeze symptoms in asthmatic children. J. Expo. Sci. Environ. Epidemiol. 24 380–387. 10.1038/jes.2014.21 [DOI] [PubMed] [Google Scholar]
  14. Horne B. D., Joy E. A., Hofmann M. G., Gesteland P. H., Cannon J. B., Lefler J. S., et al. (2018). Short-term elevation of fine particulate matter air pollution and acute lower respiratory infection. Am. J. Respir. Crit. Care Med. 198 759–766. 10.1164/rccm.201709-1883OC [DOI] [PubMed] [Google Scholar]
  15. Hsu C. Y., Chiang H. C., Lin S. L., Chen M. J., Lin T. Y., Chen Y. C. (2016). Elemental characterization and source apportionment of PM10 and PM2.5 in the western coastal area of Central Taiwan. Sci. Total Environ. 541 1139–1150. 10.1016/j.scitotenv.2015.09.122 [DOI] [PubMed] [Google Scholar]
  16. Jedrychowski W. A., Perera F. P., Spengler J. D., Mroz E., Stigter L., Flak E., et al. (2013). Intrauterine exposure to fine particulate matter as a risk factor for increased susceptibility to acute broncho-pulmonary infections in early childhood. Int. J. Hyg. Environ. Health 216 395–401. 10.1016/j.ijheh.2012.12.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jo E. J., Lee W. S., Jo H. Y., Kim C. H., Eom J. S., Mok J. H., et al. (2017). Effects of particulate matter on respiratory disease and the impact of meteorological factors in Busan, Korea. Respir. Med. 124 79–87. 10.1016/j.rmed.2017.02.010 [DOI] [PubMed] [Google Scholar]
  18. Kampa M., Castanas E. (2008). Human health effects of air pollution. Environ. Pollut. 151 362–367. 10.1016/j.envpol.2007.06.012 [DOI] [PubMed] [Google Scholar]
  19. Kendall M., Ding P., Mackay R. M., Deb R., McKenzie Z., Kendall K., et al. (2013). Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles. Nanotoxicology 7 963–973. 10.3109/17435390.2012.689880 [DOI] [PubMed] [Google Scholar]
  20. Kim S. S., Kim C. H., Kim J. W., Kung H. C., Park T. W., Shin Y. S., et al. (2017). Airborne particulate matter increases MUC5AC expression by downregulating Claudin-1 expression in human airway cells. BMB Rep. 50 516–521. 10.5483/bmbrep.2017.50.10.100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Li R., Jiang N., Liu Q., Huang J., Guo X., Liu F., et al. (2017). Impact of air pollutants on outpatient visits for acute respiratory outcomes. Int. J. Environ. Res. Public Health 14:47. 10.3390/ijerph14010047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Li Y. R., Xiao C. C., Li J., Tang J., Geng X. Y., Cui L. J., et al. (2018). Association between air pollution and upper respiratory tract infection in hospital outpatients aged 0-14 years in Hefei, China: a time series study. Public Health 156 92–100. 10.1016/j.puhe.2017.12.006 [DOI] [PubMed] [Google Scholar]
  23. Liang Y., Fang L., Pan H., Zhang K., Kan H., Brook J. R., et al. (2014). PM2.5 in Beijing – temporal pattern and its association with influenza. Environ. Health 13:102. 10.1186/1476-069X-13-102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Liu C. W., Lee T. L., Chen Y. C., Liang C. J., Wang S. H., Lue J. H., et al. (2018). PM2.5-induced oxidative stress increases intercellular adhesion molecule-1 expression in lung epithelial cells through the IL-6/AKT/STAT3/NF-kappaB-dependent pathway. Part Fibre Toxicol. 15:4. 10.1186/s12989-018-0240-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Liu J., Chen X., Dou M., He H., Ju M., Ji S., et al. (2019a). Particulate matter disrupts airway epithelial barrier via oxidative stress to promote Pseudomonas aeruginosa infection. J. Thorac. Dis. 11 2617–2627. 10.21037/jtd.2019.05.77 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Liu J., Li Y., Li J., Liu Y., Tao N., Song W., et al. (2019b). Association between ambient PM2.5 and children’s hospital admissions for respiratory diseases in Jinan, China. Environ. Sci. Pollut. Res. Int. 26 24112–24120. 10.1007/s11356-019-05644-7 [DOI] [PubMed] [Google Scholar]
  27. Ma J. H., Song S. H., Guo M., Zhou J., Liu F., Peng L., et al. (2017). Long-term exposure to PM2.5 lowers influenza virus resistance via down-regulating pulmonary macrophage Kdm6a and mediates histones modification in IL-6 and IFN-beta promoter regions. Biochem. Biophys. Res. Commun. 493 1122–1128. 10.1016/j.bbrc.2017.09.013 [DOI] [PubMed] [Google Scholar]
  28. Marsh R. L., Kaestli M., Chang A. B., Binks M. J., Pope C. E., Hoffman L. R., et al. (2016). The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx. Microbiome 4:37. 10.1186/s40168-016-0182-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Migliaccio C. T., Kobos E., King Q. O., Porter V., Jessop F., Ward T. (2013). Adverse effects of wood smoke PM(2.5) exposure on macrophage functions. Inhal. Toxicol. 25 67–76. 10.3109/08958378.2012.756086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mushtaq N., Ezzati M., Hall L., Dickson I., Kirwan M., Png K. M., et al. (2011). Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter. J. Allergy Clin. Immunol. 127 1236.e2–1242.e2. 10.1016/j.jaci.2010.11.039 [DOI] [PubMed] [Google Scholar]
  31. Pinkerton K. E., Green F. H., Saiki C., Vallyathan V., Plopper C. G., Gopal V., et al. (2000). Distribution of particulate matter and tissue remodeling in the human lung. Environ. Health Perspect. 108 1063–1069. 10.1289/ehp.001081063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pinkerton K. E., Joad J. P. (2006). Influence of air pollution on respiratory health during perinatal development. Clin. Exp. Pharmacol. Physiol. 33 269–272. 10.1111/j.1440-1681.2006.04357.x [DOI] [PubMed] [Google Scholar]
  33. Psoter K. J., De Roos A. J., Mayer J. D., Kaufman J. D., Wakefield J., Rosenfeld M. (2015). Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. Ann. Am. Thorac. Soc. 12 385–391. 10.1513/AnnalsATS.201408-400OC [DOI] [PubMed] [Google Scholar]
  34. Psoter K. J., De Roos A. J., Wakefield J., Mayer J. D., Rosenfeld M. (2017). Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis. BMC Pulm. Med. 17:106. 10.1186/s12890-017-0449-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rivas-Santiago C. E., Sarkar S., Cantarella P., IV, Osornio-Vargas A., Quintana-Belmares R., Meng Q., et al. (2015). Air pollution particulate matter alters antimycobacterial respiratory epithelium innate immunity. Infect. Immun. 83 2507–2517. 10.1128/IAI.03018-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Schlingmann B., Molina S. A., Koval M. (2015). Claudins: gatekeepers of lung epithelial function. Semin. Cell Dev. Biol. 42 47–57. 10.1016/j.semcdb.2015.04.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schulze F., Gao X., Virzonis D., Damiati S., Schneider M. R., Kodzius R. (2017). Air quality effects on human health and approaches for its assessment through microfluidic chips. Genes (Basel) 8:244. 10.3390/genes8100244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sigaud S., Goldsmith C. A., Zhou H., Yang Z., Fedulov A., Imrich A., et al. (2007). Air pollution particles diminish bacterial clearance in the primed lungs of mice. Toxicol. Appl. Pharmacol. 223 1–9. 10.1016/j.taap.2007.04.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Strickland M. J., Hao H., Hu X., Chang H. H., Darrow L. A., Liu Y. (2016). Pediatric emergency visits and short-term changes in PM2.5 concentrations in the U.S. State of Georgia. Environ. Health Perspect. 124 690–696. 10.1289/ehp.1509856 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Strosnider H. M., Chang H. H., Darrow L. A., Liu Y., Vaidyanathan A., Strickland M. J. (2019). Age-specific associations of ozone and fine particulate matter with respiratory emergency department visits in the United States. Am. J. Respir. Crit. Care Med. 199 882–890. 10.1164/rccm.201806-1147OC [DOI] [PubMed] [Google Scholar]
  41. Tsai S. S., Chang C. C., Yang C. Y. (2013). Fine particulate air pollution and hospital admissions for chronic obstructive pulmonary disease: a case-crossover study in Taipei. Int. J. Environ. Res. Public Health 10 6015–6026. 10.3390/ijerph10116015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Val S., Belade E., George I., Boczkowski J., Baeza-Squiban A. (2012). Fine PM induce airway MUC5AC expression through the autocrine effect of amphiregulin. Arch. Toxicol. 86 1851–1859. 10.1007/s00204-012-0903-6 [DOI] [PubMed] [Google Scholar]
  43. Vargas Buonfiglio L. G., Borcherding J. A., Frommelt M., Parker G. J., Duchman B., Vanegas Calderon O. G., et al. (2018). Airway surface liquid from smokers promotes bacterial growth and biofilm formation via iron-lactoferrin imbalance. Respir. Res. 19:42. 10.1186/s12931-018-0743-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Vargas Buonfiglio L. G., Mudunkotuwa I. A., Abou Alaiwa M. H., Vanegas Calderon O. G., Borcherding J. A., Gerke A. K., et al. (2017). Effects of coal fly ash particulate matter on the antimicrobial activity of airway surface liquid. Environ. Health Perspect. 125:077003. 10.1289/ehp876 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wang C., Feng L., Chen K. (2019). The impact of ambient particulate matter on hospital outpatient visits for respiratory and circulatory system disease in an urban Chinese population. Sci. Total Environ. 666 672–679. 10.1016/j.scitotenv.2019.02.256 [DOI] [PubMed] [Google Scholar]
  46. Wang L., Cheng H., Wang D., Zhao B., Zhang J., Cheng L., et al. (2019). Airway microbiome is associated with respiratory functions and responses to ambient particulate matter exposure. Ecotoxicol. Environ. Saf. 167 269–277. 10.1016/j.ecoenv.2018.09.079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Woo S. H., Lee S. M., Park K. C., Park G. N., Cho B., Kim I., et al. (2018). Effects of fine particulate matter on Pseudomonas aeruginosa adhesion and biofilm formation in vitro. Biomed. Res. Int. 2018:6287932. 10.1155/2018/6287932 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. World Health Organization [WHO] (2019). World Health Statistics 2019 Monitoring Health for the SDGs. Geneva: World Health Organization. [Google Scholar]
  49. Xia X., Zhang A., Liang S., Qi Q., Jiang L., Ye Y. (2017). The association between air pollution and population health risk for respiratory infection: a case study of Shenzhen, China. Int. J. Environ. Res. Public Health 14:950. 10.3390/ijerph14090950 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Xiao C., Li S., Zhou W., Shang D., Zhao S., Zhu X., et al. (2013). The effect of air pollutants on the microecology of the respiratory tract of rats. Environ. Toxicol. Pharmacol. 36 588–594. 10.1016/j.etap.2013.04.012 [DOI] [PubMed] [Google Scholar]
  51. Xing Y. F., Xu Y. H., Shi M. H., Lian Y. X. (2016). The impact of PM2.5 on the human respiratory system. J. Thorac. Dis. 8 E69–E74. 10.3978/j.issn.2072-1439.2016.01.19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Xu Q., Li X., Wang S., Wang C., Huang F., Gao Q., et al. (2016). Fine particulate air pollution and hospital emergency room visits for respiratory disease in urban areas in Beijing. China, in 2013. PLoS One 11:e0153099. 10.1371/journal.pone.0153099 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Yang B., Zhang Y., Li B., Zou Y., Xiao C. (2019). Fine particulate matter alters the microecology of the murine respiratory tract. Environ. Sci. Pollut. Res. Int. 26 8623–8632. 10.1007/s11356-019-04372-2 [DOI] [PubMed] [Google Scholar]
  54. Yang H. M., Antonini J. M., Barger M. W., Butterworth L., Roberts B. R., Ma J. K., et al. (2001). Diesel exhaust particles suppress macrophage function and slow the pulmonary clearance of Listeria monocytogenes in rats. Environ. Health Perspect. 109 515–521. 10.1289/ehp.01109515 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Zhang D., Tian Y., Zhang Y., Cao Y., Wang Q., Hu Y. (2019). Fine particulate air pollution and hospital utilization for upper respiratory tract infections in Beijing, China. Int. J. Environ. Res. Public Health 16:533. 10.3390/ijerph16040533 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Zhang R., Wang G., Guo S., Zamora M. L., Ying Q., Lin Y., et al. (2015). Formation of urban fine particulate matter. Chem. Rev. 115 3803–3855. 10.1021/acs.chemrev.5b00067 [DOI] [PubMed] [Google Scholar]
  57. Zhang S., Huo X., Zhang Y., Huang Y., Zheng X., Xu X. (2019). Ambient fine particulate matter inhibits innate airway antimicrobial activity in preschool children in e-waste areas. Environ. Int. 123 535–542. 10.1016/j.envint.2018.12.061 [DOI] [PubMed] [Google Scholar]
  58. Zhao C., Liao J., Chu W., Wang S., Yang T., Tao Y., et al. (2012). Involvement of TLR2 and TLR4 and Th1/Th2 shift in inflammatory responses induced by fine ambient particulate matter in mice. Inhal. Toxicol. 24 918–927. 10.3109/08958378.2012.731093 [DOI] [PubMed] [Google Scholar]
  59. Zhao H., Li W., Gao Y., Li J., Wang H. (2014). Exposure to particular matter increases susceptibility to respiratory Staphylococcus aureus infection in rats via reducing pulmonary natural killer cells. Toxicology 325 180–188. 10.1016/j.tox.2014.09.006 [DOI] [PubMed] [Google Scholar]
  60. Zheng X. Y., Ding H., Jiang L. N., Chen S. W., Zheng J. P., Qiu M., et al. (2015). Association between air pollutants and asthma emergency room visits and hospital admissions in time series studies: a systematic review and meta- analysis. PLoS One 10:e0138146. 10.1371/journal.pone.0138146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Zhou H., Kobzik L. (2007). Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 36 460–465. 10.1165/rcmb.2006-0293OC [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Cell and Developmental Biology are provided here courtesy of Frontiers Media SA

RESOURCES